Ferdinand KC - Search Results

1

Cardiorenal metabolic syndrome and cardiometabolic risks in minority populations.

Ferdinand KC, Rodriguez F, Nasser SA, Caballero AE, Puckrein GA, Zangeneh F, Mansour M, Foody JM, Pemu PE, Ofili EO. Ferdinand KC, et al. Cardiorenal Med. 2014 Apr;4(1):1-11. doi: 10.1159/000357236. Epub 2013 Dec 31. Cardiorenal Med. 2014. PMID: 24847329 Free PMC article. Review.

2

Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy.

Ofili EO, Ferdinand KC, Saunders E, Neutel JM, Bakris GL, Cushman WC, Sowers JR, Weber MA. Ofili EO, et al. Among authors: ferdinand kc. J Natl Med Assoc. 2006 Apr;98(4):618-26. J Natl Med Assoc. 2006. PMID: 16623075 Free PMC article. Clinical Trial.

3

Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes.

Sowers JR, Neutel JM, Saunders E, Bakris GL, Cushman WC, Ferdinand KC, Ofili EO, Weber MA; INCLUSIVE Investigators. Sowers JR, et al. Among authors: ferdinand kc. J Clin Hypertens (Greenwich). 2006 Jul;8(7):470-80. doi: 10.1111/j.1524-6175.2006.05486.x. J Clin Hypertens (Greenwich). 2006. PMID: 16849900 Free PMC article.

4

Hypertension in special populations: chronic kidney disease, organ transplant recipients, pregnancy, autonomic dysfunction, racial and ethnic populations.

Flack JM, Ferdinand KC, Nasser SA, Rossi NF. Flack JM, et al. Among authors: ferdinand kc. Cardiol Clin. 2010 Nov;28(4):623-38. doi: 10.1016/j.ccl.2010.07.007. Epub 2010 Sep 15. Cardiol Clin. 2010. PMID: 20937446 Review.

5

Community-based approaches to prevention and management of hypertension and cardiovascular disease.

Ferdinand KC, Patterson KP, Taylor C, Fergus IV, Nasser SA, Ferdinand DP. Ferdinand KC, et al. Among authors: ferdinand dp. J Clin Hypertens (Greenwich). 2012 May;14(5):336-43. doi: 10.1111/j.1751-7176.2012.00622.x. Epub 2012 Apr 18. J Clin Hypertens (Greenwich). 2012. PMID: 22533661 Free PMC article. Review.

6

Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy.

Ferdinand KC. Ferdinand KC. Cardiorenal Med. 2012 Dec;2(4):256-267. doi: 10.1159/000342968. Epub 2012 Oct 26. Cardiorenal Med. 2012. PMID: 23380878 Free PMC article.

7

A review of the efficacy and tolerability of combination amlodipine/valsartan in non-white patients with hypertension.

Ferdinand KC, Nasser SA. Ferdinand KC, et al. Am J Cardiovasc Drugs. 2013 Oct;13(5):301-13. doi: 10.1007/s40256-013-0033-4. Am J Cardiovasc Drugs. 2013. PMID: 23784267 Free PMC article. Review.

8

Changes in Central Aortic Pressure, Endothelial Function and Biomarkers in Hypertensive African-Americans with the Cardiometabolic Syndrome: Comparison of Amlodipine/Olmesartan versus Hydrochlorothiazide/Losartan.

Khan BV, Merchant N, Rahman ST, Ahmad M, Parrott JM, Umar K, Johnson J, Ferdinand KC. Khan BV, et al. Among authors: ferdinand kc. Cardiorenal Med. 2013 Dec;3(4):221-31. doi: 10.1159/000355136. Epub 2013 Oct 2. Cardiorenal Med. 2013. PMID: 24474950 Free PMC article.

9

Hypertension in minority populations: new guidelines and emerging concepts.

Rodriguez F, Ferdinand KC. Rodriguez F, et al. Among authors: ferdinand kc. Adv Chronic Kidney Dis. 2015 Mar;22(2):145-53. doi: 10.1053/j.ackd.2014.08.004. Adv Chronic Kidney Dis. 2015. PMID: 25704352 Review.

10

Understanding the Importance of Race/Ethnicity in the Care of the Hypertensive Patient.

Ferdinand KC, Nasser SA. Ferdinand KC, et al. Curr Hypertens Rep. 2015 Mar;17(3):15. doi: 10.1007/s11906-014-0526-9. Curr Hypertens Rep. 2015. PMID: 25754318 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

260 results

Search Page